Olarib

Olarib

(Olaparib)

Therapeutic Class:

PARP inhibitors (poly ADP-ribose polymerase inhibitors). It is a type of targeted cancer therapy and an antineoplastic agent.

Generic Name:

Olaparib

Indication:

For:

  • Treatment of certain types of ovarian, breast, pancreatic, and prostate cancers, often in patients with specific genetic mutations (such as BRCA1/2) or homologous recombination repair (HRR) gene mutations.

Supplied as:

Tablet:

    • 150mg 60s

Disclaimer:

Please consult your doctor before taking any medicine. To be sold only on prescription.